Summary
To investigate the impact of diabetic mothers on the maturation of the immune system in their offspring, immunophenotypic markers of major lymphocyte subpopulations were evaluated by two-colour flow cytometric analysis in 160 healthy children of diabetic mothers (100 with insulin-dependent diabetes mellitus (IDDM); 48 with gestational diabetes), including 22 neonates, 45 infants aged 8–12 months, 46 children aged 1–2 years, 29 children aged 3–6 years and 18 children aged 7–17 years. Results were compared with 21 neonates of healthy mothers from our hospital and with 110 paediatric subjects of a reference population. In neonates of diabetic mothers, percentages of total lymphocytes (p=0.044), T and B lymphocytes (p=0.004, respectively) were significantly decreased compared to our neonates of healthy mothers. By subdividing the group of neonates in offspring of mothers with IDDM (n=15) or gestational diabetes (n=7), differences compared to normal neonates were mainly observed in neonates of mothers with IDDM (T lymphocytes: p=0.006; B lymphocytes: p=0.008). In cord blood, 45.5% of neonates had antibodies to islet cells, insulin or glutamic acid decarboxylase, most likely transmitted through the placenta of the diabetic mother. No association was found between alterations of lymphocyte subsets and antibody-positivity in cord blood, nor was there any correlation of lymphocyte counts and mean HbA1 during pregnancy, maternal age at delivery, diabetes duration, or neonatal birth weight, respectively. Comparisons among age groups from newborn infants through adolescents revealed higher percentages of total lymphocytes and lower percentages of activated T cells in children of diabetic mothers compared to children of the reference population between the age of 1 to 6 years (67–73% of the cases above and 62–77% below the interquartiles of the reference range, respectively). No significant differences in lymphocyte subpopulations between children of mothers with IDDM diabetes and gestational diabetes have been detected. In addition, there were no abnormalities of lymphocyte subsets in children who are at high risk for the development of IDDM. In summary, we suggest that the observed changes in children of diabetic mothers may reflect a cellular immune reaction to the particular maternal environment, characterized by both an abnormal metabolic state and persisting autoimmunity in the affected mother.
Article PDF
Similar content being viewed by others
Abbreviations
- ICA:
-
Islet cell antibodies
- IAA:
-
insulin auto-antibodies
- GAD-ab:
-
antibodies to glutamic acid decarboxylase
- IDDM:
-
insulin-dependent diabetes mellitus
- FITC:
-
fluorescein isothiocyanate
- PE:
-
phycoerythrin
References
Bonifacio E, Bottazzo GF (1991) Immunology of IDDM (type 1 diabetes): entering the '90s. In: Alberti KGMM, Krall LP (eds) Diabetes annual 6. Elsevier, Amsterdam pp 20–47
Warram JH, Krolewski AS, Gottlieb MS, Kahn CR (1984) Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers. N Engl J Med 311: 149–152
Tillil H, Kobberling J (1987) Age-corrected empirical genetic risk estimates for first-degree relatives of IDDM patients. Diabetes 36: 93–99
Warram JH, Krolewski AS, Kahn CR (1988) Determinants of IDDM and perinatal mortality in children of diabetic mothers. Diabetes 37: 1328–1334
Warram JH, Martin BC, Krolewski AS (1991) Risk of IDDM in children of diabetic mothers decreases with increasing maternal age at pregnancy. Diabetes 40: 1679–1684
Ziegler A-G, Hillebrand B, Rabl W et al. (1993) On the appearance of islet associated autoimmunity in offspring of diabetic mothers: a prospective study from birth. Diabetologia 36: 402–408
Bottazzo GF, Dean BM, McNally JM, Mackay EH, Swift PG, Gamble DR (1985) In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetes mellitus. N Engl J Med 313: 353–360
Galluzzo A, Giordano C, Rubino G, Bompiani GD (1984) Immunoregulatory T-lymphocyte subset deficiency in newly diagnosed type 1 (insulin-dependent) diabetes mellitus. Diabetologia 26: 426–430
Ziegler AG, Standl E, Lander T, Nerl C, Rieber EP, Mehnert H (1987) Cell-mediated autoimmunity at onset of insulin-dependent diabetes mellitus (IDDM). Klin Wochenschr 65: 546–550
Johnston C, Alviggi L, Millward BA, Leslie RDG, Pyke DA, Vergani S (1988) Alterations in T-lymphocyte subpopulations in type 1 diabetes. Exploration of genetic influence in identical twins. Diabetes 37: 1484–1488
Faustman D, Eisenbarth G, Daley J, Breitmeyer J (1989) Abnormal T-lymphocyte subsets in type 1 diabetes. Diabetes 38: 1462–1468
Peakman M, Hussain MJ, Millward BA, Leslie RDG, Vergani D (1990) Effect of initiation of insulin therapy on T-lymphocyte activation in type 1 diabetes. Diabet Med 7: 327–330
Buschard K, Damsbo P, Röpke C (1990) Activated CD4+ and CD8+ T-lymphocytes in newly diagnosed type 1 diabetes: a prospective study. Diabet Med 7: 132–136
Peakman M, Warnock T, Vats A et al. (1994) Lymphocyte subset abnormalities, autoantibodies and their relationship with HLA DR types in children with type 1 (insulin-dependent) diabetes and their first degree relatives. Diabetologia 37: 155–165
Hitchcock CL, Riley WJ, Alamo A, Pyka R, Maclaren NK (1986) Lymphocyte subsets and activation in prediabetes. Diabetes 35: 1416–1422
Faustman D, Schoenfeld D, Ziegler R (1991) T-lymphocyte changes linked to autoantibodies. Associations of insulin autoantibodies with CD4+ CD45R+ lymphocyte subpopulation in prediabetic subjects. Diabetes 40: 590–596
Erkeller-Yuksel F, Deneys V, Yuksel B et al. (1992) Age-related changes in human blood lymphocyte subpopulations. J Pediatr 129: 216–222
Christie MR, Brown TJ, Cassidy D (1992) Binding of antibodies in sera from type 1 (insulin-dependent) diabetic patients to glutamate decarboxylase from rat tissues: evidence for antigenic and non-antigenic forms of the enzyme. Diabetologia 35: 380–384
Roll U, Christie MR, Standl E, Ziegler A-G (1994) Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type 1 diabetic patients. Diabetes 43: 154–160
Ziegler AG, Ziegler R, Vardi P, Jackson RA, Soeldner JS, Eisenbarth GS (1989) Lifetable analysis of progression to diabetes of anti-insulin autoantibody positive relatives of individuals with type 1 diabetes. Diabetes 38: 1320–1325
Greenbaum CJ, Wilkin TJ, Palmer JP (1992) Fifth international serum exchange workshop for insulin autoantibody (IAA) standardization. Diabetologia 35: 798–800
Greenbaum CJ, Palmer JP, Nagataki S et al. (1992) Improved sensitivity of ICA assays in the fourth international immunology of diabetes serum exchange workshop. Diabetes 41: 1570–1574
Ziegler AG, Hillebrand B, Standl E (1993) Inselzellantikörper und Insulin-Autoantikörper bei Schwangeren mit Gestationsdiabetes. Eine postpartale Verlaufsbeobachtung. Diabetes und Stoffwechsel 2: 51–55
Buschard K, Kühl C, Molsted-Petersen L, Lund E, Palmer J, Bottazzo GF (1989) Investigations in children who were in utero at onset of insulin-dependent diabetes in their mothers. Lancet I: 811–814
Di Mario U, Dotta F, Gargiulo P et al. (1987) Immunology in diabetic pregnancy: activated T cells in diabetic mothers and neonates. Diabetologia 30: 66–71
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roll, U., Scheeser, J., Standl, E. et al. Alerations of lymphocyte subsets in children of diabetic mothers. Diabetologia 37, 1132–1141 (1994). https://doi.org/10.1007/BF00418377
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00418377